← Home / Revolution Medicines, Inc. (RVMD)
Stock Analysis
Revolution Medicines, Inc. (RVMD)
RVMD
RVMD · Market data
187.53 -2.41%
Track RVMD in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when RVMD price is:
52W Range Position
97%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-08-02 16:45 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 192.62. Holding above 171.93 keeps the current thesis intact.
⚖️
✓
Fundamentals
Weak / Insufficient
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
171.93
↗
Break Above
Confirmation improves above resistance.
192.62
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 171.93
Recent Company Events
SEC VERIFIED
Latest material filings
JUN
22
●
Management / Board
MEDIUM
RVMD board and management update
On June 18, 2026, Steve Kelsey, M.D., FRCP, FRCPath, informed Revolution Medicines, Inc.
8-K Filing • SEC EDGAR
MAY
6
●
Financial Results
HIGH
Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress
(Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced its financial results for the quarter ended March 31, 2026, and provided an update on corporate progress.
8-K Filing • SEC EDGAR
What's Driving RVMD?
📈 Technical recovery is improving
Momentum is Neutral. Watch 192.62 for confirmation and 171.93 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 176.38 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Technical Setup Active
✓
An active technical structure is present. Use trigger, target, stop and watch levels for context.
Pattern
Triangle Compression / SYM / DOWN
State
Back Inside
Trigger
186.47
Risk / Invalid
158.03
Compression
40%
RSI(14)
56.1
◎
How to read this setup
Active technical structure detected. Use the chart overlays, support, resistance and invalidation levels to manage confirmation and risk.
Price Chart
RVMD — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-31
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$37.5B
Company size
EV
$37.1B
Debt-adjusted value
P/E
-27.4
Not meaningful
P/B
25.0
Very high
EV/EBIT
-26.8
Not meaningful
P/FCF
-35.0
Not meaningful
FCF Yield
-2.85%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial context is mixed
Financial conditions require selective monitoring.
↗
Revenue Growth
Weak
●
Profitability
Insufficient
≈
Cash Flow
Pressured
⚖
Balance Sheet
Strong
💵 Revenue
0.00
↘ Weak
📈 Net Income
-453.82M
≈ Insufficient
🧮 EPS (Basic)
-2.29
≈ Insufficient
Revolution Medicines, Inc.
Related Opportunities